miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1

microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling

(2018) Ri-sheng Huang et al.   BIOMEDICINE & PHARMACOTHERAPY

MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B

(2018) Fang Xiao et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Correction to: MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy

(2018) Wei-Wei Ren et al.   Cell Death & Disease

MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression

(2017) Qinghua Cao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Regulation of multidrug resistance by microRNAs in anti-cancer therapy

(2017) Xin An et al.   Acta Pharmaceutica Sinica B

Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1

(2015) Yan Liang et al.   BIOMEDICINE & PHARMACOTHERAPY

miR-381 suppresses C/EBP -dependent Cx43 expression in breast cancer cells

(2015) J. Ming et al.   BIOSCIENCE REPORTS

Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

(2014) Qiong Wu et al.   CANCER LETTERS

MicroRNAs in cancer: biomarkers, functions and therapy

(2014) Josie Hayes et al.   TRENDS IN MOLECULAR MEDICINE

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O

(2013) Binghai Chen et al.   JOURNAL OF CHEMOTHERAPY

MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells

(2013) A Formosa et al.   ONCOGENE

Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance

(2013) Yan Xu et al.   PLoS One

Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo

(2013) Wen-Juan Wang et al.   PLoS One

Overcoming multidrug-resistancein vitroandin vivousing the novel P-glycoprotein inhibitor 1416

(2012) Yan Xu et al.   BIOSCIENCE REPORTS

Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells

(2012) Hengrui Zhu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth

(2011) Hailin Tang et al.   BRAIN RESEARCH

Emerging Role of MicroRNAs in Drug-Resistant Breast Cancer

(2011) SARMILA MAJUMDER et al.   GENE EXPRESSION

MicroRNA and drug resistance

(2010) J Ma et al.   CANCER GENE THERAPY

A Brief Review on the Mechanisms of miRNA Regulation

(2010) Yimei Cai et al.   GENOMICS PROTEOMICS & BIOINFORMATICS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

(2008) Hua Zhu et al.   BIOCHEMICAL PHARMACOLOGY

Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer

(2008) Helen M. Coley   CANCER TREATMENT REVIEWS